Chemical activators of PPARGC1 and ESRR induced regulator, muscle 1 play a significant role in modulating this protein's activity through different pathways. Resveratrol, a well-known antioxidant, has been shown to activate SIRT1, an enzyme that can enhance PPARGC1 and ESRR induced regulator, muscle 1 activity through a process called deacetylation. Similarly, SRT1720, another SIRT1 activator, promotes the deacetylation of PPARGC1 and ESRR induced regulator, muscle 1, thereby enhancing its activity. Quercetin also activates SIRT1, which in turn can lead to the activation of this muscle-specific protein. The activation of SIRT1 by these chemicals suggests a regulatory mechanism that involves the modification of PPARGC1 and ESRR induced regulator, muscle 1, which is crucial for its functional activity.
Moreover, several chemicals activate AMPK, a master regulator of cellular energy homeostasis, which in turn promotes the activity of PPARGC1 and ESRR induced regulator, muscle 1. Metformin, a drug commonly used to manage blood glucose levels, activates AMPK, which can lead to the activation of PPARGC1 and ESRR induced regulator, muscle 1. AICAR and its form 5-Aminoimidazole-4-carboxamide ribonucleotide both serve as AMPK activators, setting off a cascade of events that result in the activation of PPARGC1 and ESRR induced regulator, muscle 1. Berberine is another chemical that activates AMPK, which likewise leads to the activation of this protein. Furthermore, chemicals like Pioglitazone, Bezafibrate, ZLN005, and GW501516 activate various PPAR isoforms. Pioglitazone, a PPARγ agonist, and ZLN005 and GW501516, which are PPARβ/δ agonists, result in the activation of PPARGC1 and ESRR induced regulator, muscle 1 through improved mitochondrial functionality and other related mechanisms. Lastly, 4-Hydroxytamoxifen, an estrogen receptor agonist, may activate PPARGC1 and ESRR induced regulator, muscle 1 through pathways associated with the estrogen receptor, adding another layer of regulation that can promote the activity of this muscle-specific protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates SIRT1, which in turn enhances the activity of PPARGC1 and ESRR induced regulator, muscle 1 by deacetylation. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin activates AMPK, leading to increased phosphorylation and activation of PPARGC1 and ESRR induced regulator, muscle 1. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Pioglitazone, a PPARγ agonist, indirectly activates PPARGC1 and ESRR induced regulator, muscle 1 by improving mitochondrial function. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR activates AMPK, which can enhance the activity of PPARGC1 and ESRR induced regulator, muscle 1 through phosphorylation. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $30.00 $45.00 $120.00 $200.00 | 5 | |
Bezafibrate activates PPAR isoforms, which can lead to increased activity of PPARGC1 and ESRR induced regulator, muscle 1. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine activates AMPK, which subsequently enhances the activity of PPARGC1 and ESRR induced regulator, muscle 1. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin activates SIRT1, which may lead to the deacetylation and activation of PPARGC1 and ESRR induced regulator, muscle 1. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $193.00 $357.00 | 13 | |
SRT1720 is a SIRT1 activator, which can deacetylate and enhance the activity of PPARGC1 and ESRR induced regulator, muscle 1. | ||||||
(Z)-4-Hydroxytamoxifen | 68047-06-3 | sc-3542C sc-3542 sc-3542B sc-3542A sc-3542D sc-3542E | 1 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $216.00 $275.00 $400.00 $704.00 $1350.00 $2350.00 | 20 | |
4-Hydroxytamoxifen, an agonist of the estrogen receptor, may activate PPARGC1 and ESRR induced regulator, muscle 1 through ER-related pathways. | ||||||
ZLN005 | 49671-76-3 | sc-474381A sc-474381 sc-474381B sc-474381C | 5 mg 10 mg 25 mg 50 mg | $44.00 $112.00 $156.00 $257.00 | ||
ZLN005 directly activates PPARβ/δ, which can increase the activity of PPARGC1 and ESRR induced regulator, muscle 1. |